Delivery Order SPE2DB24D2106-SPE2DB25FAUHH

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, from the Defense Logistics Agency (DLA). The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $10,408.51 and a period of performance through January 28, 2025. This contract is not associated with a specific set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,728.45 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has no set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product, with a ceiling value of $39,794.36 and a period of performance through June 11, 2024. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite...
This is a $31,320.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with an ultimate completion date of September 21, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $55,064.59 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products to fulfill the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $35,289.60 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,268.96 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,610.08 and covers the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialized pharmaceutical product, with a performance period ending on March 29, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $47,563.78 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery...
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $15,751.69 firm fixed-price delivery order is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The delivery order was issued against an indefinite delivery vehicle (IDV) contract, SPE2DB24D2106|SPE2DB24FAUAA, with a ceiling value of up to $4,999,999 through 2025. This IDV contract enables DLA to place orders for a broad range of...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAUHH
    Delivery Order

This federal contract award is for a delivery order with the Defense Logistics Agency (DLA) for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $32,628.10 and a period of performance through January 8, 2025. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. There is no set-aside designation associated with this specific delivery order.

Generated 4/8/25, 9:57 AM